Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 4 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Royalty Pharma plc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 315 | 364 | +49 |
| Shares | 299.8M | 311.3M | +11.5M (+3.8%) |
| Value | $8.17B | $8.74B | +$574.8M (+7.0%) |
New holders (78)
Institutions that held Royalty Pharma plc at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (29)
Institutions that held Royalty Pharma plc at the end of Q3 2023 and filed for Q4 2023 without it.